Evidium
PrivateLast Round
Series A
Nov 10, 2025
Total Funding Raised
$22M
Company Overview
Evidium operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Series A round in November 2025.
Evidium is a healthcare technology company that provides a neurosymbolic AI platform to transform clinical knowledge into computational models for care delivery and insurance environments.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Evidium Comparables
Compare Evidium with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Atropos Health | 79% | |
| Vera Health | 77% | |
| AvoMD | 73% |
For institutional investors. Book with your work email.
Evidium Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Evidium Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Health2047 | Series A |
| Interwoven Ventures | Series A |
| WGG Partners | Series A |
| Mindset Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 20, 2026
Developing a computational medical intelligence layer for healthcare.
For institutional investors. Book with your work email.
Evidium Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Evidium's valuation, stock price, and market status.
Is Evidium a public or private company?
Evidium is a private company.
What is the current stock price of Evidium?
Evidium is a private company, so its shares have no public market price. Caplight tracks Evidium's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Evidium worth (valuation)?
Valuation information for Evidium is not publicly available.
Can I buy Evidium stock?
Evidium shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Evidium's last funding round?
Evidium's most recent funding round was Series A on November 10, 2025.
Who are the main investors in Evidium?
Key investors in Evidium include Health2047, WGG Partners.
Will Evidium IPO soon?
No public IPO plans have been announced for Evidium.
How can I track Evidium secondary market activity?
Caplight tracks bids, offers, and trades in Evidium's shares on secondary markets.